SCHEMBL25762500

SCHEMBL25762500

CC(C)(C)OC(=O)CCN(CC1CCCC1)C(=O)OCOP(=O)(OC(C)(C)C)OC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30452223 0.85 GHSR (0.31) —
SCHEMBL25293713 0.82 — —
SCHEMBL25271325 0.82 — —
SCHEMBL25787628 0.82 CA12 (0.30) —
SCHEMBL25278203 0.82 CA14 (0.30) —
SCHEMBL25762551 0.81 — —
SCHEMBL25255776 0.81 — —
SCHEMBL25683482 0.81 — —
SCHEMBL25762502 0.80 MEN1 (0.31) —
SCHEMBL25257371 0.79 CA14 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203071-A1 THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION GILEAD SCIENCES, INC. 2023-06-29 — — US disclosed
Send feedback